Innervace
Develops regenerative therapy solutions for neurodegenerative disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
$160—240m (Dealroom.co estimates Sep 2022.)
Philadelphia Pennsylvania (HQ)
Authorizing premium user...